The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 902, Issue , 2012, Pages 151-156

  Goey, Andrew K L ^a   Rosing, Hilde ^b   Meijerman, Irma ^a   Sparidans, Rolf W ^a   Schellens, Jan H M ^a,b   Beijnen, Jos H ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Alkylamide; Dodeca 2E,4E,8Z,10E Z tetraenoic acid isobutylamides; Echinacea purpurea; Human plasma; LC MS MS

Indexed keywords

ALKYLAMIDE; DODECA-2E,4E,8Z,10E/Z-TETRAENOIC ACID ISOBUTYLAMIDES; ECHINACEA PURPUREA; HUMAN PLASMAS; LC-MS/MS;

ACETONITRILE; FORMIC ACID; HEXANE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY;

PLASMA (HUMAN);

ACETONITRILE; AMIDE; DODECA 2,4,8,10 TETRAENOIC ACID ISOBUTYLAMIDE; ECHINACEA PURPUREA EXTRACT; ECHINAFORCE; FORMIC ACID; UNCLASSIFIED DRUG; WATER;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHROMATOGRAPHY; DRUG BLOOD LEVEL; ECHINACEA PURPUREA; EVAPORATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; PARTICLE SIZE; PRIORITY JOURNAL;

CHROMATOGRAPHY, LIQUID; DRUG STABILITY; ECHINACEA; FATTY ACIDS, UNSATURATED; HUMANS; LINEAR MODELS; PLANT EXTRACTS; POLYUNSATURATED ALKAMIDES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ECHINACEA PURPUREA;

EID: 84864100838     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.06.022     Document Type: Article

References (14)

1. Cech N.B., Eleazer M.S., Shoffner L.T., Crosswhite M.R., Davis A.C., Mortenson A.M. J. Chromatogr. A 2006, 1103:219.
2. Spelman K., Wetschler M.H., Cech N.B. J. Pharm. Biomed. Anal. 2009, 49:1141.
3. Woelkart K., Bauer R. Planta Med. 2007, 73:615.
4. Matthias A., Blanchfield J.T., Penman K.G., Toth I., Lang C.S., De Voss J.J., Lehmann R.P. J. Clin. Pharm. Ther. 2004, 29:7.
5. Ardjomand-Woelkart K., Kollroser M., Magnes C., Sinner F., Frye R.F., Derendorf H., Bauer R., Butterweck V. Planta Med. 2011, 77:1794.
6. Matthias A., Addison R.S., Penman K.G., Dickinson R.G., Bone K.M., Lehmann R.P. Life Sci. 2005, 77:2018.
7. Woelkart K., Koidl C., Grisold A., Gangemi J.D., Turner R.B., Marth E., Bauer R. J. Clin. Pharmacol. 2005, 45:683.
8. Woelkart K., Marth E., Suter A., Schoop R., Raggam R.B., Koidl C., Kleinhappl B., Bauer R. Int. J. Clin. Pharmacol. Ther. 2006, 44:401.
9. Woelkart K., Dittrich P., Beubler E., Pinl F., Schoop R., Suter A., Bauer R. Planta Med. 2008, 74:651.
10. Chen Y., Fu T., Tao T., Yang J., Chang Y., Wang M., Kim L., Qu L., Cassady J., Scalzo R., Wang X. J. Nat. Prod. 2005, 68:773.
11. Gertsch J., Schoop R., Kuenzle U., Suter A. FEBS Lett. 2004, 577:563.
12. Woelkart K., Xu W., Pei Y., Makriyannis A., Picone R.P., Bauer R. Planta Med. 2005, 71:701.
13. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001.
14. Goey A.K., Sparidans R.W., Meijerman I., Rosing H., Schellens J.H., Beijnen J.H. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879:41.